摘要: Tremendous progress in the ability to predict outcome patients with cutaneous melanoma has come about through careful prospective studies of clinical and histopathologic features primary tumors. Observations biologic behavior seem be generalizable over wide geographic areas. For example, tumor Australia appears similar that observed United States which turn for light skin Europeans. Awareness these prognostic factors allow physician categorize into low, indeterminate, high risk groups. This facilitates 1) patient counselling; 2) matching extent surgery severity tumor; 3) construction groups comparable evaluation therapeutic (adjuvant) trials; 4) understanding tumor.
springer.com
springerlink.com参考文章(79)
CALVIN L. DAY, MARTIN C. MIHM, ARTHUR J. SOBER, MATTHEW N. HARRIS, ALFRED W. KOPF, THOMAS B. FITZPATRICK, ROBERT A. LEW, TERENCE J. HARRIST, FREDERICK M. GOLOMB, ALLEN POSTEL, PATRICK HENNESSEY, STEPHEN L. GUMPORT, JOHN W. RAKER, RONALD A. MALT, A. BENEDICT COSIMI, WILLIAM C. WOOD, DANIEL F. ROSES, FRED GORSTEIN, DARRELL RIGEL, ROBERT J. FRIEDMAN, MEDWIN M. MINTZIS, Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Annals of Surgery. ,vol. 195, pp. 30- 34 ,(1982) , 10.1097/00000658-198201001-00005
John C. Maize, Primary cutaneous malignant melanoma. Journal of The American Academy of Dermatology. ,vol. 8, pp. 857- 863 ,(1983) , 10.1016/S0190-9622(83)80017-6
H. M. Shaw, V. J. McGovern, G. W. Milton, G. A. Farago, W. H. McCarthy, Histologic features of tumors and the female superiority in survival from malignant melanoma Cancer. ,vol. 45, pp. 1604- 1608 ,(1980) , 10.1002/1097-0142(19800401)45:7<1604::AID-CNCR2820450715>3.0.CO;2-O
Lynn G. Feun, Jordon Gutterman, M. Andrew Burgess, Evan M. Hersh, Giora Mavligit, Robert S. Benjamin, Stephen P. Richman, William K. Murphy, Gerald P. Bodey, Barry W. Brown, Emil J. Freireich, Charles M. McBride, Clifton F. Mountain, Milam E. Leavens, The natural history of resectable metastatic melanoma (Stage IVA Melanoma) Cancer. ,vol. 50, pp. 1656- 1663 ,(1982) , 10.1002/1097-0142(19821015)50:8<1656::AID-CNCR2820500833>3.0.CO;2-L
Michael A. Gromet, William L. Epstein, Marsden S. Blois, The regressing thin malignant melanoma. A distinctive lesion with metastatic potential Cancer. ,vol. 42, pp. 2282- 2292 ,(1978) , 10.1002/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO;2-V
D R Vlock, J M Kirkwood, Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes. Journal of Clinical Investigation. ,vol. 76, pp. 849- 854 ,(1985) , 10.1172/JCI112042
V. J. McGOVERN, H. M. SHAW, G. W. MILTON, W. H. McCARTHY, Ulceration and prognosis in cutaneous malignant melanoma Histopathology. ,vol. 6, pp. 399- 407 ,(1982) , 10.1111/J.1365-2559.1982.TB02737.X
Calvin L. Day, Martin C. Mihm, Arthur J. Sober, Matthew N. Harris, Alfred W. Kopf, Thomas B. Fitzpatrick, Robert A. Lew, Terence J. Harrist, Frederick M. Golomb, Allen Postel, Patrick Hennessey, Stephen L. Gumport, John W. Raker, Ronald A. Malt, A. Benedict Cosimi, William C. Wood, Daniel F. Roses, Fred Gorstein, Darrell Rigel, Robert J. Friedman, Medwin M. Mintzis, Predictors of Late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis Journal of The American Academy of Dermatology. ,vol. 8, pp. 864- 868 ,(1983) , 10.1016/S0190-9622(83)80018-8
Charles M. Balch, Tariq M. Murad, Seng-Jaw Soong, Anna Lee Ingalls, Peter C. Richards, William A. Maddox, Tumor thickness as a guide to surgical management of clinical stage I melanoma patients Cancer. ,vol. 43, pp. 883- 888 ,(1979) , 10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO;2-V
M Albert Robin, M G Jégu, Syphilitic Affections of the Ear Annals of Surgery. ,vol. 8, pp. 65- ,(1888) , 10.1097/00000658-188807000-00029